Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib
Curr Med Res Opin. 2013 Sep;29(9):1075-82
View abstract
Authors
Goldberg SL, Chen L,
Guerin A, Macalalad AR, Liu N, Kaminsky M, Ericson SG,
Wu EQ